Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl-L-carnitine Supplementation in Chronic Hepatitis C
NCT01909557Phase 3Completed
- Sponsor
- University of Catania
- Start
- Jan 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hepatitis C (HCV) comparing Acetyl-L-carnitine with Placebo (2 arms). Primary endpoint: Work performances at 12 months. Started Jan 2010; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01909557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01909557.